Herbalife Ltd. — FY 2012 Form 10-K
Reporting period: Fiscal year ended December 31, 2012. This is an annual report, not a standalone Q4 filing; quarterly figures are included below for context. The company sells nutrition and personal-care products through independent distributors in 88 countries, with a distinct China sales model.
Financial performance
| Metric | FY 2012 | FY 2011 | Change |
|---|---|---|---|
| Net sales | $4.072 billion | $3.455 billion | +17.9% reported; +22.6% in local currency |
| Gross profit / margin | $3.260 billion / 80.1% | $2.774 billion / 80.3% | Margin down 0.2 percentage points |
| Operating income / margin | $661.4 million / 16.3% | $562.3 million / 16.3% | Operating income +17.6% |
| Net income / diluted EPS | $477.2 million / $4.05 | $412.6 million / $3.30 | Net income +15.7% |
| Operating cash flow | $567.8 million | $509.3 million | +11.5% |
| Cash / working capital | $333.5 million / $247.0 million | $258.8 million / $220.1 million | Both increased |
| Total debt | $487.6 million | $203.6 million | Increased; primarily credit-facility borrowings |
Q4 2012 net sales were $1.059 billion versus $884.6 million in Q4 2011; net income was $117.9 million versus $105.4 million, and diluted EPS was $1.05 versus $0.86. Weight management generated 62.7% of FY sales; Formula 1 alone represented approximately 29%.
Growth was attributed mainly to distributor engagement, recruiting, and daily-consumption methods such as Nutrition Clubs. All regions grew in reported sales, although EMEA growth was modest at 2.0%. Sales leaders’ retention outside China improved to 52.0% from 48.9%.
Cash, debt and capital allocation
- FY capital expenditures were $122.8 million; management expected $165–185 million in 2013, including investment in the Winston-Salem manufacturing facility.
- At year-end, $487.5 million was outstanding under the credit facility, with $695.2 million of undrawn capacity; the company reported compliance with debt covenants. The facility is variable-rate and matures in 2016.
- FY 2012 share repurchases were approximately $527.8 million and dividends paid or declared were $135.1 million. A new $1 billion repurchase authorization was approved in July 2012.
- By February 19, 2013, total credit-facility borrowings had risen to approximately $987.5 million, with about $195.2 million of unused capacity; approximately 4.0 million shares had been repurchased in January and February.
Outlook, risks and unusual items
- The filing provides no earnings or revenue guidance. Management’s stated priorities include growing existing markets, expanding daily-consumption initiatives, launching products, and investing in manufacturing and distribution.
- China’s tax holiday ended in 2012; the company expected its China tax rate to rise from 12.5% in 2012 to the statutory 25% in 2013.
- In February 2013, Venezuela announced elimination of the 5.3 Bolivars-per-dollar SITME rate and a 6.3 CADIVI rate. The company estimated that applying the new rate to year-end Venezuelan net monetary assets and liabilities could produce an approximately $14 million pretax loss and reduce reported Bolivar cash by about $16 million.
- After late-2012 allegations about the legality of its marketing program and a sharp share-price decline, SEC Division of Enforcement staff requested information about the company’s business and financial operations; Herbalife said it would cooperate. The filing also reports unusually high short interest and heightened share-price volatility.
- A Belgian court had ruled against the local subsidiary’s marketing program; the subsidiary appealed, and the company described the ruling as flawed. Material tax audits and disputes remain unresolved, including Mexican VAT matters; the company said losses were not probable or could not be reasonably estimated for specified matters.
- Other key exposures include distributor conduct and retention, product and advertising regulation, network-marketing scrutiny, foreign exchange, China licensing and regulation, supplier dependence, product liability, and transfer-pricing and tax assessments. The company reported effective disclosure controls and internal control over financial reporting; the auditor issued unqualified opinions.
Investor verification priorities
- Verify subsequent SEC inquiry developments and the status and outcome of the Belgian appeal and other challenges to the marketing model.
- Assess the effect of Venezuela’s currency changes on cash recoverability, reported earnings, and the company’s ability to continue importing products.
- Track borrowing, covenant headroom, repurchases, and dividends after year-end, particularly given the sharp increase in debt.
- Review distributor-retail demand and retention indicators, and whether sales growth remains broad-based and supported by product consumption.
- Monitor tax disputes and the 2013 China tax-rate increase, alongside planned capital spending and manufacturing expansion.